Summary Fibroblast growth factors (FGFs) and fibroblast growth factor receptors (FGFRs) have been increasingly recognized to play an important role in the pathobiology of pancreatic malignancy. We have investigated the effects of FGF-1 and FGF-2 on the behaviour and adhesion properties of human pancreatic adenocarcinoma cell lines (BxPc3, T3M4 and HPAF) that were previously characterised for the expression of FGFRs. Here we show that exposure to FGF-1 and FGF-2 leads to significant and dose-dependent increase in E-cadherindependent cell-cell adhesion, tubular differentiation, and a reduced capacity to invade collagen gels. FGF stimulation produces phosphorylation of E-cadherin and β-catenin on tyrosine residues, as well as increased E-cadherin localisation to the cytoplasmic membrane and association with FGFR1 demonstrable by coimmunoprecipitation. These results demonstrate that FGF-1 and FGF-2 may be involved in the regulation of cell adhesion, differentiation and invasion of pancreatic cancer. © Cancer Research Campaign http://www.bjcancer.com
Changes in cell adhesion, regulated by environmental signals such as growth factors, appear to be necessary for dynamic cellular movement and maintenance of tissue patterning. E-cadherin is well-established as playing a suppressive role in the progression of malignant disease (Takeichi, 1991) . Selective reduction or loss of E-cadherin is correlated not only with dedifferentiation, but also with the invasive phenotype in vitro and in vivo Pignatelli et al, 1992) . This has been reported in pancreatic carcinoma, where loss of membranous E-cadherin correlated with high grade and advanced tumour stage (Pignatelli et al, 1994) . Furthermore, the role of E-cadherin in tumour progression has been explored using specific inhibitors and gene transfer experiments. Transfection of E-cadherin-negative colorectal carcinoma cells with E-cadherin cDNA restores not only their capacity for intercellular adhesion but also results in reversal of the invasive phenotype (Liu et al, 1993) .
A growing body of evidence suggests a role for the FGF/FGFR system in the modulation of cell adhesion and cell migration. It has been demonstrated that neurite outgrowth responses stimulated by cell adhesion molecules (CAMs) are mediated via FGFR, probably as a direct consequence of an interaction via the CAM homology domain (Doherty et al, 1995) . FGFR-CAM interaction was further substantiated by identifying and characterizing a CAM homology domain (CHD) within the extracellular domains of FGFR, with similarity to regions found in L1, NCAM (VASE motif) (Williams et al, 1994) and N-cadherin (HAV motif) (Byers et al, 1992) . These regions in CAMs have been implicated in the mediation of homophilic interactions between cadherin molecules. Subsequently, anti-FGFR antibodies and CHD peptides were both shown to inhibit neurite outgrowth responses to cell adhesion molecules and FGF-2 (Doherty et al, 1995) .
Finally, indirect evidence comes from observations that the expression levels and/or functions of growth factor receptor tyrosine kinases (RTK) and E-cadherin may be co-ordinated. In this context, β-catenin has been shown to associate with at least two receptor tyrosine kinases: epidermal growth factor receptor (EGFR) (Hoschuetzky et al, 1994 ) and c-erB-2 (Kanai et al, 1995) . Ligand-induced activation of these receptors also results in increased tyrosine phosphorylation of β-catenin and subsequent impaired cadherin/catenin function by a mechanism that is still poorly understood.
We have examined the possible involvement of E-cadherin in determining the invasive phenotype of pancreatic carcinomas and investigated whether E-cadherin functions can be modulated by stimulation with exogenous FGF-1 and FGF-2 in a panel of human pancreatic adenocarcinoma cell lines that express different combinations of FGFRs.
MATERIALS AND METHODS

Cell lines
Human pancreatic adenocarcinoma cell lines that express various combinations of FGFRs (Leung et al, 1994) and exhibit different grades of differentiation were used. The BxPc3 cell line (American Type of Culture Collection (ATCC), Rockville, Maryland) is a moderately to well differentiated cell line derived from a primary tumour (Tan et al, 1986 ) and expresses FGFR-1; the T3M4 cell line is a moderately differentiated cell line, which was derived from a lymph node metastasis (Okabe et al, 1983 ) and expresses FGFR-3; and the HPAF cell line which is a moderately to poorly differentiated cell line that was derived from ascitic fluid (Metzgar et al, 1982) and is FGFR-3 and FGFR-4 positive. All cell lines were maintained in standard medium.
FGF-1 and FGF-2 modulate the E-cadherin/catenin system in pancreatic adenocarcinoma cell lines
Growth factors and antibodies
Human recombinant FGF-1 and FGF-2 (Upstate Biotechnology, Lake Placid, NY, USA) were used for stimulation of the cell lines at various concentrations between 1 ng/ml and 50 ng/ml. Heparin was added at 10 µg/ml and 1 µg/ml with FGF-1 and FGF-2, respectively, as shown to be suitable for FGFR activation by FGFs in this tissue type (Leung et al, 1994) .
The mouse monoclonal anti-human E-cadherin antibody, HECD-1, was kindly provided by Prof. Takeichi (Kyoto University, Kyoto, Japan). Mouse monoclonal anti-human E-cadherin, α-, β-and γ-catenin antibodies were purchased from Transduction Laboratories, Exeter, UK. The monoclonal anti-Ep-CAM (AUA-1) and anti-CEA (PR3B10) antibodies were kindly provided by Sir Walter Bodmer (ICRF). The anti-FGFR antibodies used in the study were anti-FGFR-1 antibodies (8E10 (Prizm Pharmaceuticals) and VBS6 (Santa Cruz)). Anti-phosphotyrosine antibody 4G10 was purchased from Upstate Biotechnology.
Cell-cell adhesion assay
Cells were grown to 90% confluence, washed twice in PBS, and subsequently treated with 2 mM EDTA for 10 min at 37˚C. Detached cells were washed once with RPMI medium and were passed through Pasteur pipettes several times to obtain single cells. Cells were then re-suspended in either Ca 2+ -free PBS/0.8% FCS or RPMI/0.8% FCS (controls). In FGF stimulation experiments, FGF-1 or FGF-2 was added to the medium at concentrations of 1, 5, 10, 20, and 50ng/ml at the time of initiation of the assay. Cells were then inoculated at 5×10 5 cells/ml into 24-well plates (500µl/well) that had been coated overnight with 1% (w/v) bovine serum albumin in PBS to prevent non-specific cell adhesion to wells. Cells were allowed to aggregate for 1 h at 37˚C on a gyratory shaker with constant rotation at 90 rpm. Cell aggregation was terminated by the addition of 4% (w/v) glutaraldehyde fixative to individual wells at 0, 15, 30, 45 or 60 min. Aliquots were taken at each time point and the number of single cells was then determined with a Coulter counter (Coulter Electronics, Inc.). Cell-cell adhesion was assessed by the cell aggregation index (Nt/NO), where Nt is the number of single cells after the incubation time, and NO is the number of single cells at the initiation of the assay.
Blocking of E-cadherin-mediated cell adhesion
Experiments were carried out as above except that cell suspensions were incubated with 10 µg/ml anti-E-cadherin (HECD-1) antibody for 30 min before the initiation of the assay. The extent of inhibition of cell adhesion was represented as percent inhibition (Ni/Nc X 100%), where Ni is the number of single cells in the presence of anti-E-cadherin antibody and Nc is number of single cells in the absence of the antibody (control).
In vitro invasion system in collagen gel
Collagen gels were prepared by mixing eight volumes of icecold collagen type I stock solution (Vitrogen 100, Imperial Laboratories, UK) with one volume of 10X DMEM containing phenol red indicator and neutralised with 0.1 M NaOH. Aliquots (1 ml) were added into 35 mm tissue culture dishes and incubated for 1 h at 37˚C in a 10% CO 2 incubator. After gelation, 1X10 5 cells re-suspended in 1 ml of RPMI/1% FCS alone (control) or supplemented with FGF-1 or FGF-2 (1, 5, 10, or 20 ng/ml) were seeded onto the gel. Cells were re-fed every 3 days for 10 days with the standard medium alone (control) or supplemented with FGF, and growth was assessed daily using a phase contrast microscope. Gels were finally fixed in 10% formaldehyde overnight, paraffin embedded, serially sectioned in vertical orientation (5 µm sections), stained with haematoxylin and eosin and photographed. The number of cells that invaded the gel in 10 randomly selected graticule areas from duplicate cultures was determined. The degree of invasion was represented by the invasion index (Nv/Nc), where Nv is the number of invading cells in stimulated cultures and Nc is the number of invading cells in control cultures. In some experiments, serial dilutions of monoclonal anti-E-cadherin (HECD-1), anti-CEA and anti-EP-CAM antibodies were added to the culture medium for five consecutive days. Purified mouse immunoglobulins (50µg/ml) were also used as control in these experiments.
Morphogenic assay in 3-D collagen gels
Experiments were carried out as above except that 1ml of the single cell suspension was mixed with 10 volumes of the neutralized vitrogen solution to yield a final concentration of 1×10 5 cells/ml, and the solution was allowed to gel at 37˚C. Gels were then overlaid with the standard medium alone (control) or medium supplemented with FGF-1 or FGF-2 (10 ng/ml), that was replaced every 4 days for 21 days. Plates were checked daily for the appearance of glandular structures using a phase-contrast microscope.
Immunohistochemistry
Sections prepared from the morphogenic assay were deparaffinized in xylene and rehydrated in graded alcohols. An avidinbiotin peroxidase method was applied. Tris-buffered saline (TBS) was used in all washing steps. Non-specific binding was blocked with normal rabbit serum, and sections were probed with optimally diluted primary antibody for 2 h, washed, and then incubated with biotinylated rabbit anti-mouse antibody (Dakopatts, Denmark; 1:200) for 30 min, followed by freshly prepared avidinbiotin-peroxidase complex (ABC) for 30 min. Sections were developed in 0.05% (w/v) diaminobenzidine (DAB) and 0.03% (v/v) hydrogen peroxide in PBS, counterstained in haematoxylin and mounted. As a negative control, the primary antibody was replaced by TBS. The sections were assessed for the subcellular localisation of E-cadherin and catenins (membranous, cytoplasmic, mixed membranous and cytoplasmic). The staining intensity of E-cadherin and catenins were also graded semiquantitatively using an arbitrary scale of intensity: -(no expression); + (increased expression); and +/-(equivocal expression).
Immunoprecipitation and immunoblotting
These experiments were performed as previously described (ElHariry et al, 1999) . Briefly, cell lysates (soluble fraction) were precleared and incubated with anti-E-cadherin, anti-α-, anti-β-, and anti-γ-catenin antibodies overnight at 4˚C with rotation. Immune-complexes were precipitated with 50 µl/ml protein G-sepharose, and the immunoprecipitates were resolved by SDS-PAGE and transferred onto nitrocellulose membranes (Millipore, Herts, UK) for immunoblotting. After non-specific binding was blocked, membranes were probed overnight with: (i) anti-E-cadherin (1 µg/ml); (ii) anti-β-catenin, 1 µg/ml; (iii) anti-α-catenin, 4 µg/ml and (iv) anti-γ-catenin, 1 µg/ml. Membranes were incubated with peroxidase-conjugated secondary anti-mouse antibodies (Dako Ltd, Bucks, UK; 0.5 µg/ml) for 2 h at room temperature, washed, and then were reacted with enhanced chemiluminescence reagent (ECL; Amersham Life Sciences, Bucks, UK) and exposed to Hyperfilm-MP film (Amersham Life Sciences, Bucks, UK). Cell lysates immunoprecipitated with IgG were used as a control for the antibody specificity.
The protein levels were assessed by densitometric analysis using ImageQuant image analysis software package (Molecular Dynamics, Inc, Bucks, UK). Results were presented in arbitrary units of the integrated optical density (OD). All experiments were repeated twice.
Statistical analysis
Where the effect of either FGF-1 or FGF-2 was compared to the control samples, the significance of differences between groups was calculated by the Student's two-tailed t-test. The mean and the standard deviation (SD) were calculated from at least three separate experiments. The effect of FGF-1 and FGF-2 on cell-cell adhesion as a function of FGF doses was computed using the analysis of variance (F-test) to compare the difference between control, FGF-1 and FGF-2. The level of significance was taken as P < 0.05.
RESULTS
Cell-cell adhesion in pancreatic cell lines
In the absence of Ca 2+ , all pancreatic cell lines showed poor spontaneous aggregation, but they readily formed cell aggregates in the presence of Ca 2+ . The increase in cell aggregation was small but statistically significant. This finding indicated that cell-cell adhesion was mediated by a Ca 2+ -dependent mechanism. Since this aggregation was significantly blocked by the addition of the monoclonal anti-E-cadherin antibody (HECD-1), it was apparent that E-cadherin was the most likely candidate implicated in cellcell adhesion and was functionally active in these cell lines. As additional controls, incubation with anti-CEA and anti-EP-CAM antibodies did not block cell-cell adhesion in Ca 2+ -supplemented cell suspension (RPMI medium), thus giving further evidence for the specificity of E-cadherin-mediated effects.
Both FGFs significantly increased cell aggregation in BxPc3 (P < 0.01), T3M4 (P < 0.001) and HPAF cell lines (P < 0.001) only in the presence of Ca 2+ , Figure 1 (A-C). FGFs appeared to modulate the kinetics of the cell-cell adhesion. For instance, in HPAF cells, while half-maximal aggregation was not reached until 55 min in untreated cells, it occurred within ~15 min in cells treated with FGF-2 and FGF-1, Figure 1C . Furthermore, cell aggregates appeared large and coalescent in the presence of FGF-1 or FGF-2 as opposed to small and irregular aggregates in untreated cells.
The modulation of cell-cell adhesion by FGFs was E-cadherindependent, since anti-E-cadherin antibody inhibited the effect of FGF-1 and FGF-2 on cell-cell adhesion almost completely in the three cell lines, Figure 1D . In contrast, the modulatory effect of FGF-1 or FGF-2 was not blocked by the treatment of cell suspensions with anti-CEA and anti-EP-CAM antibodies in Ca 2+ -supplemented or Ca 2+ -free medium. The effect of FGF-1 and FGF-2 on cell-cell adhesion is dose-dependent in the range of 1 ng/ml to 20 ng/ml, which was statistically significant, Figure 1E .
In vitro invasion into collagen gel
The cell lines used in the current study varied in their migratory ability through the gel matrix. Figure 2 depicts the effect of FGF-1 and FGF-2 on the invasive behaviour of these cell lines. Both BxPc3 and T3M4 cell lines grew into the gel front as solid sheets or as confluent irregular islands of cells, and exhibited a weak to moderate invasive capacity. FGF-treated cells became more cohesive and less invasive. HPAF cells assumed a pleomorphic appearance and were markedly invasive. In the presence of FGF-1 or FGF-2, cells became more cohesive than control untreated cultures and less invasive into the collagen. The effect of FGFs was demonstrated at concentrations as low as as 1 ng/ml and up to 20 ng/ml. The effect of FGF was Ecadherin-mediated, since it was abrogated by treatment with HECD-1 antibody, but not with anti-CEA, anti-EP-CAM antibodies or purified mouse IgG.
Morphogenic assay in 3-D collagen gels
Stimulation with FGF-1 or FGF-2 did not produce any discernible effects on morphogenesis in either BxPc3 or T3M4 cells. In contrast, both FGF-1 and FGF-2 induced glandular differentiation in HPAF cells, where organised structures consisting of a single layer of cells with basally arranged nuclei around a central lumen were observed, Figure 3 .
FGFs increase tyrosine phosphorylation of E-cadherin/catenin system
In addition, tyrosine phosphorylation of E-cadherin and catenins was examined. Serum-starved cells were treated with medium alone or supplemented with either FGF-1 or FGF-2 for 15 min. Lysates were immunoprecipitated with anti-E-cadherin, anti-α-catenin, anti-β-catenin or anti-γ-catenin antibodies, separated by SDS-PAGE, and the immunoblots were probed with antiphosphotyrosine antibody. Figure 4 depicts the tyrosine phosphorylation of E-cadherin and catenins in control and FGF-stimulated cells. Both FGF-1 and FGF-2 induced approximately 2-fold increase in the tyrosine phosphorylation of E-cadherin in BxPc3 cells ( Figure 4A, lanes 2 and 3) , as compared to 3-fold and 6-fold increase in HPAF cells respectively, Figure 4A , lanes 8 and 9. Similarly, both FGFs induced an approximately 2-fold increase in tyrosine phosphorylation of β-catenin in both cell lines ( Figure  4C, lanes 2, 3, 8 and 9) , and α-catenin in only HPAF cells, Figure  4B , lanes 8 and 9. While both FGFs produced an increase in tyrosine phosphorylation of β-catenin ( Figure 4C , lane 5), they had only a marginal effect on E-cadherin, α-catenin, or γ-catenin in T3M4 cells.
FGFs upregulate the expression of E-cadherin and catenins
Formalin-fixed, paraffin-embedded sections of the control and FGF-treated cells were stained with anti-E-cadherin, anti-α, anti-β-and anti-γ-catenin antibodies. As shown in Table 1 , both FGF-1 and FGF-2 up-regulated the expression of E-cadherin and/or one or more of the catenins. The immunoreactivity of E-cadherin ( Figure 5A ), β-catenin ( Figure 5B ) and γ-catenin was restricted to membranous localisation on FGF stimulation.
Physical association of FGFs and E-cadherin/catenin
We next examined the possibility of a physical association between the E-cadherin/catenin and FGFR systems. Ecadherin/catenin complexes from confluent cultures of BxPc3 cells grown in standard medium were immunoprecipitated with antibodies against E-cadherin, β-catenin and FGFR-1, and the immunoblots were probed with either anti-E-cadherin or anti-FGFR-1 antibodies. As shown in Figure 6A , E-cadherin was detected as a faint band in FGFR-1 immunoprecipitates. In the reciprocal experiments, these immunoprecipitates were probed with anti-FGFR-1 antibody. As shown in Figure 6B , FGFR-1 comigrated with E-cadherin immunoprecipitates as a fainter signal (lane 2), and with β-catenin (lane 3). In similar experiments, no association was detected between FGFR-1 and either α-catenin or γ-catenin (data not shown). These findings suggest that the association of FGFR-1 with the E-cadherin/catenin system in BxPc3 cells may primarily involve β-catenin.
In the second set of experiments, BxPc3 cells were serumstarved, and then stimulated with FGF-2 (50 ng/ml) for 24 h. Cell extracts were immunoprecipitated with anti-E-cadherin and anti-FGFR-1 antibodies, and the immunoblots were probed with anti-E-cadherin antibody. As shown in Figure 6C , E-cadherin was detected in FGFR-1 immunoprecipitates from both FGF-treated and untreated cell extracts (lanes 1 and 2 respectively).
Furthermore, E-cadherin was markedly increased in FGF-treated cells (lane 3) as compared to control (lane 4).
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DISCUSSION
Increasing evidence suggests that changes in the expression levels and/or functional state of RTK and E-cadherin may be related cellular events that are associated with tumour progression (Hoschuetzky et al, 1994; Kanai et al, 1995) . The potential involvement of the FGF/FGFR system in E-cadherin-mediated functions is less well explored. FGF/FGFR interaction was reported to modulate the neurite outgrowth function of NCAM (Williams et al, 1994) . Similar to other RTKs, signals mediated by FGF/FGFR induce a multitude of cellular activities from differentiation to proliferation. These observations prompted us to investigate: (a) the possible involvement of FGF/FGFR in the modulation of the functional activities of E-cadherin/catenin system, and (b) possible molecular interactions between FGFR and the E-cadherin/catenin complex. Cell lines used in this study displayed adhesive ability that was Ca 2+ -dependent and E-cadherin-mediated. Both FGFs modulated cell-cell adhesion from a sluggish to an accelerated rate and from a weak to a strong adhesion state. The rapidity of cell adhesion suggested that FGFs led to a direct activation of E-cadherin complexes, rather than modulation of expression of E-cadherin. A possible explanation is that FGFs lead to a rapid relocalisation of E-cadherin to the plasma membrane and subsequent recruitment of E-cadherin and catenins into complexes. This view is supported by our observations that the components of the E-cadherin/catenin complex partition into plasma-bound and cytosolic pools in these cell lines (El-Hariry et al, 1999) . Additionally, the formation of large compact aggregates in response to FGFs may suggest increased coupling of the E-cadherin/catenin system to the actin cytoskeleton (El-Hariry, unpublished data) and subsequent increase in E-cadherin adhesive ability.
These findings add further support to the observations that various growth factors exert distinct effects on the E-cadherin/-catenin system. While the adhesive function of E-cadherin/catenin complex can be restored by insulin-like growth factor I (IGF-I) in human breast cancer MCF-7/6 cells (Bracke et al, 1993) , other growth factors such as EGF were shown to reduce E-cadherinmediated cell-cell adhesion and perturb its association with cytoskeletal proteins (Hazan and Norton, 1998) .
We also demonstrated that the pancreatic cell lines differed in their invasive ability, which can be modulated by FGFs. The invasive ability of these cell lines was not suppressed completely in the presence of FGFs, which emphasizes the fact that other molecular mechanisms play a role in the invasion process. Modulation of Ecadherin function was also observed in the presence of insulin-like growth factor I (IGF-I) (Bracke et al 1991) , and tamoxifen (Bracke et al, 1994) . Taken together, FGFs could be added to the growing list of factors that lead to the modification of E-cadherin functions.
An interesting finding in the present study was the induction of differentiation in the HPAF cell line. FGFs are known for their pleiotropic effects in vivo that include mitogenic, migratory and differentiation responses (Roghani and Moscatelli, 1992) . FGFs may induce a morphogenic process through augmentation of cellcell and/or cell-stromal interactions. In this regard, FGF-2 has been shown not only to upregulate many integrin receptors in vitro and in vivo, but also potentiate their adhesive and signalling functions (Kinoshita et al, 1993; Miyamoto et al, 1996) . Interestingly, cross-talk has recently been reported between E-cadherin and α2β1 integrin (Pignatelli et al, 1997) ; the latter plays an essential role in epithelial renewal and promotes terminal differentiation of cultured keratinocytes (Watt and Hertle, 1994) . The cell surface proteoglycans -in addition to their role in FGF/FGFR system activation -appear to play an important role in maintaining the epithelial phenotype and modulating the expression of E-cadherin and integrins (Day et al, 1999; Kato et al, 1995; Leppa et al, 1996) . Taken together, the FGF/FGFR system may influence the differentiation process by regulating the coordinated activities of both cellcell and cell-matrix machinery.
The present findings are in contrast to the reports suggesting that overexpression of FGFs and FGFRs may be associated with short survival of patients with pancreatic adenocarcinoma (Ohta et al, 1995; Yamanaka et al, 1993) . However, it is difficult to draw a firm conclusion in the light of the following observations. The studies to date have included a relatively small number of patients, and it is important to match cases carefully for other factors contributing to survival. Importantly, these studies have shown a correlation between FGF-1 or FGF-2 (with or without coexpression of FGFR) and advanced stage, in no case was the overexpression of FGF and/or FGFR an independent prognostic factor for survival. The nuclear localization of a high molecular weight form of FGF-2 in these studies may also suggest differential effects of FGF-2 in the milieu of the tumour microenvironment. Interestingly, paradoxical findings have been observed in other systems (Blanckaert et al, 1998; McLeskey et al, 1994; Smith et al, 1999; Wang et al, 1997) .
The potential involvement of FGF/FGFR in E-cadherin-mediated functions is less well explored. In contrast to our findings, FGF-1 has been found to induce a dysfunctional state of Ecadherin in a rat bladder cell line (Boyer et al, 1992) . However, a role for the FGF/FGFR system in the modulation of cell-cell adhesion, invasion and morphogenesis is supported by observations in other systems. The expression of dominant-negative FGFR in PCI2 neuronal cells prevents neurite outgrowth in response to L1, N-CAM or N-cadherin (Saffel et al, 1997) . In a recent report, FGF-2 completely inhibited colony formation in soft agar in SK-N-MC cell lines via binding to FGFR, and resulted in the acquisition of a less transformed and more differentiated phenotype (van Puijenbroek et al, 1997) . The FGFs-induced effects on E-cadherin/catenin function(s) may suggest a post-translational mechanism via modulation of the phosphorylation/dephosphorylation state of one or more components of the cadherin/catenin system. Increased tyrosine phosphorylation of catenins has previously been correlated with the abrogation of cell-cell adhesion . Recently however, it has been reported that in primary mouse keratinocytes, β-catenin, γ-catenin and p120 ctn become phosphorylated at tyrosine residues upon induction of differentiation with Ca 2+ treatment (Calautti et al, 1998) . These observations suggest that posttranslational modification of the E-cadherin system may be cell-type or system-dependent, and hence warrants further investigation.
We have demonstrated a physical association between FGFR-1 and the E-cadherin/catenin system in pancreatic cancer cells. Interestingly, the data suggest that the interaction may primarily involve association between FGFR-1 and β-catenin. Other RTK such as erb-B2 and EGFR have been reported to associate with Ecadherin/catenin system (Hoschuetzky et al, 1994; Kanai et al, 1995) . It is possible that FGFR-E-cadherin/catenin interaction facilitates the functional cross-talk between the two systems, and exerts positive regulatory cues as opposed to the negative effects of EGFR. Immunoprecipitates with mouse IgG anti-serum were used as controls for antibody reactivity (lane 4). (C) Serum-starved B×Pc3 cells were stimulated with 50 ng/ml FGF-2 for 24 h, and equal aliquots of cell extracts were immunoprecipitated with anti-FGFR-1 (lanes 1 and 2) or anti-E-cadherin (lanes 3 and 4) antibodies. Proteins were separated by SDS-PAGE, transferred onto nitrocellulose membranes, and probed with anti-E-cadherin antibody. Immunoprecipitates with mouse IgG anti-serum were used as controls for antibody reactivity (lane 5). Molecular mass markers are indicated by arrows
